The Global Pharma pipeline holds significant promise across areas of high unmet medical need, particularly in cardiometabolic disease, with multiple assets advancing into Phase II and III. With late-stage development programs and anticipated launches, Global Pharma is well positioned to drive future growth and meaningful patient impact. Within Global Pharma team, it’s an exciting time as we build an industry-leading cardiometabolic & Neuroscience business that aspires to impact these devastating diseases on a global scale. Our company has made significant progress with advancing our cardiometabolic and rare disease pipeline this year. Moreover, we expect 8 approvals in the next five years across our broad and exciting portfolio. The Executive Director, Global Commercial Leader, Cardiometabolic will lead three key pipeline products within our company’s expanding cardiometabolic portfolio, with a focus on MASH, obesity & inflammation. These assets have the potential to become best-in-class products and generate blockbuster revenue. In addition, the team will continue to manage inline diabetes brands and our alliance with Bayer. The Global Commercial Leader will play an important role in supporting the commercial transformation and leadership of our launches, pipeline including new ways of working, embedding advanced analytics, evolving the commercial models and building value for patients, payers and HCP. This role will also support the commercial leadership in our Business Development efforts to help support growth and leadership in this space.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive